Autolus Therapeutics plc (AUTL) Q4 2024 Earnings Conference Call Transcript

2025-03-20 11:55:19 ET

Autolus Therapeutics plc (AUTL)

Q4 2024 Earnings Conference Call

March 20, 2025, 08:30 AM ET

Company Participants

Amanda Cray - IR

Christian Itin - CEO

Rob Dolski - CFO

Conference Call Participants

James Shin - Deutsche Bank

Rajan Sharma - Goldman Sachs

Asthika Goonewardene - Truist

Matt Phipps - William Blair

Gil Blum - Needham & Company

Kelly Shi - Jefferies

Yanan Zhu - Wells Fargo

Jacob Mekhael - KBC Securities

Simon Baker - Redburn Atlantic

Presentation

Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Call to Discuss the Full Year 2024 Financial Results and Business Updates. As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Amanda Cray. Please go ahead.

Amanda Cray

Thank you, Tanya. Good morning or good afternoon, everyone, and thank you for joining us on today's call. With me, our Chief Executive Officer, Dr. Christian Itin, and Chief Financial Officer, Rob Dolski.

I'd like to remind you that during today's call, we will make statements related to our business that are forward-looking under federal securities laws and the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These may include, but are not limited to, statements regarding status of the ongoing commercial launch of AUCATZYL in the U.S., Autolus manufacturing, sales, and marketing plans for AUCATZYL, the market potential for AUCATZYL, and the status of clinical trials and development and or regulatory timelines for obe-cel and our other product candidates. These statements are subject to a variety of risks and uncertainties that could cause actual results to differ materially from expectations and reflect our views only as of today. We assume no obligation to update any such forward-looking statement.

For a discussion of the material risks and uncertainties that could affect our actual results, please refer to the risks identified in today's press release and in our SEC filings, both available on the investor section of our website.

On Slide 3, you'll see the agenda for today's call. As usual, Christian will provide an overview of our operational highlights. Rob will then discuss the financial results, and Christian will conclude with upcoming milestones and closing remarks. We will then take your questions....

Read the full article on Seeking Alpha

For further details see: